| Unique ID issued by UMIN | UMIN000063674 |
|---|---|
| Receipt number | R000072701 |
| Scientific Title | Fixed very-low-dose oral immunotherapy using a standardized food product for children with severe peanut, walnut or cashew allergy |
| Date of disclosure of the study information | 2026/11/20 |
| Last modified on | 2026/11/18 11:18:48 |
Fixed very-low-dose oral immunotherapy using a standardized food product for children with severe peanut, walnut or cashew allergy
Fixed very-low-dose oral immunotherapy for children with severe peanut, walnut or cashew allergy
Fixed very-low-dose oral immunotherapy using a standardized food product for children with severe peanut, walnut or cashew allergy
Fixed very-low-dose oral immunotherapy for children with severe peanut, walnut or cashew allergy
| Japan |
Food allergy
| Pediatrics |
Others
NO
This study aims to compare the proportion of children with severe peanut, walnut, or cashew allergy who achieve short-term unresponsiveness (STU) to 0.5 g of the respective allergen after a 2-week avoidance period, following 12 months of fixed very-low-dose oral immunotherapy (OIT) administered either daily or twice weekly.
Others
As a secondary objective, this study aims to compare the safety and adherence of fixed very-low-dose oral immunotherapy (OIT) between the daily and twice-weekly administration groups.
The proportion of patients who achieve short-term unresponsiveness (STU), defined as the ability to consume the entire 0.5 g dose of the target allergenic food without developing allergic symptoms during an oral food challenge (OFC) performed after a 2-week avoidance period, 12 months after the initiation of the intervention.
Frequency and severity of adverse reaction during home ingestion.
Changes in allergen-specific IgE and IgG4 levels at baseline and months 1, 3, 6, and 12.
The positive rate of the baseline 0.02 g OFC among provisionally enrolled patients, as well as the characteristics and severity of allergic reactions, treatments required, age, sex, and allergen-specific IgE and IgG4 levels.
Adherence to study-product ingestion assessed by participant diaries.
STU rates after 12 months for each culprit food (peanut, walnut, and cashew).
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Dose comparison
YES
2
Treatment
| Food |
Daily group: Participants eat consuming one unit of the standardized food product containing 0.02 g of the culprit food (peanut, walnut, and cashew) once daily at home from the following day for 12 months.
Twice-weekly group: Participants eat consuming one unit of the standardized food product containing 0.02 g of the culprit food (peanut, walnut, and cashew) twice weekly at home from the following day for 12 months.
| 3 | years-old | <= |
| 18 | years-old | > |
Male and Female
Patients with a positive OFC to 0.5 g or less of peanut, walnut, or cashew (one culprit food per participant, even if more than one qualifies), ability to undergo a 0.02g OFC within one year after the qualifying OFC and written informed consent from a legally authorized representative, or from the participant and representative, as applicable. Only participants with a negative baseline 0.02g OFC proceed to full registration and randomization.
Poorly controlled asthma (Childhood Asthma Control Test [C-ACT] or Asthma Control Test [ACT] score <= 19)
Severe atopic dermatitis (Eczema Area and Severity Index [EASI] score >= 16)
Treatment with a biologic agent, systemic Janus kinase (JAK) inhibitor, systemic corticosteroid, or immunosuppressant
Concomitant immune-related disease, including autoimmune disease, immune-complex disease, or immunodeficiency
Any other condition judged by the investigator to make participation inappropriate
120
| 1st name | Noriyuki |
| Middle name | |
| Last name | Yanagida |
National Hospital Organization Sagamihara National Hospital
Department of pediatrics
252-0392
18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan
042-742-8311
k.nagakura@foodallergy.jp
| 1st name | Ken-ichi |
| Middle name | |
| Last name | Nagakura |
National Hospital Organization Sagamihara National Hospital
Department of pediatrics
252-0392
18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan
042-742-8311
k.nagakura@foodallergy.jp
National Hospital Organization Sagamihara National Hospital
none
Self funding
Japan
National Hospital Organization Sagamihara National Hospital
18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan
042-742-8311
makino.megumi.bn@mail.hosp.go.jp
NO
| 2026 | Year | 11 | Month | 20 | Day |
Unpublished
Enrolling by invitation
| 2026 | Year | 10 | Month | 20 | Day |
| 2026 | Year | 10 | Month | 20 | Day |
| 2026 | Year | 11 | Month | 11 | Day |
| 2029 | Year | 03 | Month | 31 | Day |
| 2026 | Year | 11 | Month | 18 | Day |
| 2026 | Year | 11 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072701